Skip to content

MUSic Therapy to Improve Quality Of Life in Sickle Cell Disease (MUSIQOLS)

MUSic Therapy to Improve Quality Of Life in Sickle Cell Disease (MUSIQOLS): A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03556657
Enrollment
24
Registered
2018-06-14
Start date
2018-08-27
Completion date
2018-12-30
Last updated
2019-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Sickle Cell Disease

Keywords

Music Therapy, Sickle Cell Disease, Quality of Life, Chronic Pain

Brief summary

The purpose of this pilot study is to investigate the effects of a 6-session music therapy protocol on the pain, mood, quality of life, coping skills, and self-efficacy of adult patients with sickle cell disease (SCD) as compared to adult patients with SCD who receive standard care alone. The investigators will also determine the feasibility (delivery, acceptability, and usefulness) of the music therapy intervention for pain management and quality of life.

Interventions

OTHERMusic Therapy

Patient receives 6 sessions of music therapy with a board-certified music therapist. Patient will learn various music interventions for pain management that he/she will utilize at home.

Sponsors

Kulas Foundation
CollaboratorOTHER
University Hospitals Cleveland Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is 18 years or older * Subject has a SCD diagnosis * Subject fits chronic pain criteria in SCD * Subject has a working email address * Subject has access to a mobile device with email and internet capabilities * Subject is able to speak and understand English * Subject has attended at least 50% of his/her scheduled outpatient visits to the Adult SCD Clinic in the last 12 months

Exclusion criteria

* Subject has a significant visual impairment that has not been corrected * Subject has a significant hearing impairment that has not been corrected * Subject has a significant cognitive impairment that would prevent subject from participating in the study

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference - Short Form 4aPre-test at baseline and post-test at 10 weeksPain interference (4 questions)
Change from baseline in Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-Me)Pre-test at baseline and post-test at 10 weeksA patient-reported outcome measurement system that addresses the physical, social, and emotional impact of SCD. ASCQ-Me scores are calculated in the direction of overall health, with higher ASCQ-Me scores indicating better health.
Change from baseline in Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress-Anxiety Short Form 4aPre-test at baseline and post-test at 10 weeksAnxiety (4 questions)
Change from baseline in Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress-Depression - Short Form 4aPre-test at baseline and post-test at 10 weeksDepression (4 questions)
Change from baseline in Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue - Short Form 4aPre-test at baseline and post-test at 10 weeksFatigue (4 questions)
Change from baseline in Patient-Reported Outcomes Measurement Information System (PROMIS) Ability to Participate in Social Roles and Activities - Short Form 4aPre-test at baseline and post-test at 10 weeksAbility to participate in social roles and activities (4 questions)
Change from baseline in Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Short Form 4aPre-test at baseline and post-test at 10 weeksPhysical function (4 questions)

Secondary

MeasureTime frameDescription
Change from baseline in Sickle Cell Self-Efficacy Scale (SCSES)Pre-test at baseline and post-test at 10 weeksA nine-item Likert scale originally developed for adults with SCD to assess patients' beliefs in their ability to manage their own SCD.
Change from baseline in Coping Skills Questionnaire - Sickle Cell Disease (CSQ-SCD)Pre-test at baseline and post-test at 10 weeks80-item questionnaire that assesses coping strategies relevant to SCD
Electronic Sickle Cell Disease Pain DiaryDaily entries for 2 weeks at baseline and daily entries for 2 weeks post-interventionA multidimensional pain diary assessing daily pain intensity, location, description, cause, and interference with daily activities
Change from baseline in Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance - Short Form 4aPre-test at baseline and post-test at 10 weeksSleep disturbance (4 questions)

Other

MeasureTime frameDescription
Semi-structured interviewAt post-test at 10 weeksInterview questions will focus on the patient's current pain, his/her experience of the music therapy sessions, and whether anything could have been done differently to improve the music therapy sessions.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026